Ceftazidime retains in vivo efficacy against strains of Stenotrophomonas maltophilia for which traditional testing predicts resistance
ABSTRACT Stenotrophomonas maltophilia is responsible for a growing number of nosocomial infections and is difficult to treat owing to limited antibiotic susceptibilities. However, there are numerous recently published examples where traditional susceptibility testing methodology fails to accurately...
Saved in:
| Main Authors: | Matthew C. Phillips, Bosul Lee, Sarah L. Miller, Jun Yan, Kristine Goy, Marlène Maeusli, Tina Lam, Catherine Spellberg, Michael Spellberg, Rosemary She, Brad Spellberg, Brian Luna |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2025-06-01
|
| Series: | mSphere |
| Subjects: | |
| Online Access: | https://journals.asm.org/doi/10.1128/msphere.00840-24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia Infections
by: Mohammed Al Musawa, et al.
Published: (2025-06-01) -
Synergistic combination of aztreonam and ceftazidime/avibactam against resistant Stenotrophomonas maltophilia on pancreatitis
by: Natália de Almeida Torres, et al.
Published: (2023-06-01) -
Sporadic Stenotrophomonas maltophilia Respiratory Infections in Cancer Patients
by: Mahua Sinha1, et al.
Published: (2025-03-01) -
Roles of the rpoEc-chrR-chrA operon in superoxide tolerance and β-lactam susceptibility of Stenotrophomonas maltophilia
by: Ren-Hsuan Ku, et al.
Published: (2025-02-01) -
Piperacillin-tazobactam: prospects for use in real-world practice
by: Yu. M. Gomon
Published: (2023-10-01)